| Literature DB >> 29113066 |
Abstract
Polyphenols are plant metabolites with potent anti-oxidant properties, which help to reduce the effects of oxidative stress-induced dreaded diseases. The evidence demonstrated that dietary polyphenols are of emerging increasing scientific interest due to their role in the prevention of degenerative diseases in humans. Possible health beneficial effects of polyphenols are based on the human consumption and their bioavailability. Common beans (Phaseolus vulgaris L.) are a greater source of polyphenolic compounds with numerous health promoting properties. Polyphenol-rich dry common beans have potential effects on human health, and possess anti-oxidant, anti-diabetic, anti-obesity, anti-inflammatory and anti-mutagenic and anti-carcinogenic properties. Based on the studies, the current comprehensive review aims to provide up-to-date information on the nutritional compositions and health-promoting effect of polyphenol-rich common beans, which help to explore their therapeutic values for future clinical studies. Investigation of common beans and their impacts on human health were obtained from various library databases and electronic searches (Science Direct PubMed, and Google Scholar).Entities:
Keywords: Phaseolus vulgaris; anti-oxidants; degenerative diseases; health-promoting effects; polyphenols
Mesh:
Substances:
Year: 2017 PMID: 29113066 PMCID: PMC5713300 DOI: 10.3390/ijms18112331
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Nutritional compositions of common beans in 100 g of edible portion [58,59,60].
| Nutrient | Units | Navy Beans | Kidney Beans | Red Beans | Black Beans | Pinto Beans | Cranberry Beans |
|---|---|---|---|---|---|---|---|
| Energy | kcal | 92 | 92 | 167 | 464 | 500 | 257 |
| Protein | g | 6.15 | 5.38 | 22.22 | 14.29 | 10.71 | 22.86 |
| Total lipid (fat) | g | 0.00 | 0.38 | 0.00 | 21.43 | 21.43 | 0.00 |
| Carbohydrate | g | 16.15 | 20.77 | 63.89 | 57.14 | 60.71 | 60.00 |
| Total dietary fiber | g | 4.6 | 5.4 | 44.4 | 14.3 | 10.7 | 25.7 |
| Total sugars | g | 0.00 | 0.77 | 2.78 | 3.57 | 3.57 | 2.86 |
| Resistant starch | g | 4.2 | 2.0 | 3.8 | 1.7 | 1.9 | 2.6 |
| Calcium | mg | 62 | 46 | 167 | 143 | 71 | 114 |
| Iron | mg | 1.38 | 1.38 | 7.29 | 3.86 | 2.57 | 5.1 |
| Potassium | mg | 300 | 268 | 222 | 279 | 96 | 265 |
| Magnesium | mg | 48 | 37 | 44 | 60 | 43 | 39 |
| Sodium | mg | 108 | 8 | 69 | 286 | 286 | 10 |
| Vitamin C | mg | 0.9 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Folate | µg | 127 | 115 | 140 | 128 | 147 | 124 |
| Total saturated | g | 0.000 | 0.000 | 0.000 | 1.790 | 1.790 | 0.000 |
| Total monounsaturated fatty acids | g | 0.000 | 0.000 | 0.000 | 14.290 | 14.290 | 0.000 |
| Total polyunsaturated fatty acids | g | 0.000 | 0.000 | 0.000 | 5.360 | 5.360 | 0.000 |
| Polyphenol | mg of gallic acid equiv/g | 12.47 | 14.14 | 13.68 | 12.60 | 12.52 | 11.73 |
| Flavonoids | mg of rutin equiv/g | 1.78 | 2.59 | 1.55 | 1.28 | 0.98 | 1.65 |
List of polyphenols in the common beans.
| Bean Name | Polyphenol Class | Polyphenol Sub-Class | Compound Name | References |
|---|---|---|---|---|
| Dark bean | Flavonoids | Anthocyanins | Cyanidin 3- | [ |
| Wild and weedy Mexican bean, pinto and black beans | Flavonoids | Anthocyanins | Peonidin, pelargonidin, cyanidin | [ |
| Dark bean, Wild, and weedy Mexican bean | Flavonoids | Anthocyanins | Delphinidin 3- | [ |
| Alubia, black, cranberry, dark red kidney, great northern, light red kidney, navy, pink, pinto, and small red | Flavonoids | Anthocyanins | Petunidin 3- | [ |
| Dark and kidney bean, zolfino landraces | Flavonoids | Anthocyanins | Pelargonidin 3,5- | [ |
| Alubia, black, cranberry, dark red kidney, great northern, light red kidney, navy, pink, pinto, and small red | Flavonoids | Anthocyanins | Delphinidin 3- | [ |
| Dark bean | Flavonoids | Flavanols | (+)-Catechin, (-)-epicatechin, (+)-gallocatechin, procyanidin dimer, (-)-epigallocatechin, Procyanidin dimer B2, procyanidin dimer B3, procyanidin dimer B4, procyanidin trimer, procyanidin trimer EEC, naringenin 7-glucoside | [ |
| Dark bean | Flavonoids | Flavanones | Naringenin, hesperetin, naringin, naringenin 7- | [ |
| Dark bean | Flavonoids | Flavones | Apigenin, apigenin 7- | [ |
| Brazilian bean | Flavonoids | Flavones | Chrysin | [ |
| Dark bean, Brazilian bean, Mexican bean | Flavonoids | Flavonols | Kaempferol | [ |
| Dark bean, Brazilian bean, Mexican bean | Flavonoids | Flavonols | Quercetin | [ |
| Dark bean, and Brazilian bean | Flavonoids | Flavonols | Quercetin 3- | [ |
| Pinto beans, zolfino landraces | Flavonoids | Flavonols | Kaempferol 3- | [ |
| Alubia, black, cranberry, dark red kidney, great northern, light red kidney, navy, pink, pinto, and small red | Flavonoids | Flavonols | Kaempferol 3- | [ |
| Pinto beans | Flavonoids | Flavonols | Kaempferol 3- | [ |
| Dark bean, Brazilian bean | Flavonoids | Isoflavonoids | Daidzein | [ |
| Dark bean, Brazilian bean | Flavonoids | Isoflavonoids | Genistein | [ |
| Dark bean | Flavonoids | Isoflavonoids | Biochanin A | [ |
| Pinto and black beans | Flavonoids | Isoflavonoids | Glycitein | [ |
| Dark bean | Flavonoids | Isoflavonoids | Dihydrogenistein | [ |
| Brazilian bean | Polyphenols | Polyphenols | Coumestrol | [ |
| Dark bean, pinto and black beans, Mexican bean | Phenolic acids | Hydroxybenzoic acids | Protocatechuic acid | [ |
| Dark bean | Phenolic acids | Hydroxybenzoic acids | Gallic acid | [ |
| Mexican bean | Phenolic acids | Hydroxybenzoic acids | Vanillic acid | [ |
| Dark bean, Mexican bean | Phenolic acids | Hydroxycinnamic acids | [ | |
| Pinto and black beans | Phenolic acids | Hydroxycinnamic acids | Caffeic acid | [ |
| Dark bean, Mexican bean | Phenolic acids | Hydroxycinnamic acids | Ferulic acid | [ |
| Dark bean | Phenolic acids | Hydroxycinnamic acids | Sinapic acid, Ferulic acid 4-glucoside | [ |
| Dark bean | Stilbenes | Stilbenes | [ |
Figure 1Health promoting effects of polyphenol-rich dry common beans.
Summary of in vitro, in vivo and clinical studies on health-promoting effects of polyphenol-rich common beans (Phaseolus vulgaris L.).
| Bean Name | Polyphenols Names | Model/Subjects | Dosage | Experimental Period | Activities | References |
|---|---|---|---|---|---|---|
| Kidney bean | 62.5 to 500 µg/mL | 36–48 h | Anti-bacterial activity | [ | ||
| Perla black bean | Delphinidin 3- | Bacterial strain: | 0.05, 0.5 and 5.0 mg/disk | 36–48 h | Anti-bacterial and anti-parasitic activity | [ |
| Peruvian and Brazilian bean | In vitro | 50 µL | 24 h | Anti-diabetic and anti-hypertensive activity | [ | |
| Brown bean | Total phenolics | Human (16)-randomized crossover design | 100 g/bw/p.o. | 30 days | Anti-diabetic and anti-obesity activity | [ |
| Kidney bean | Total phenolics and anthocyanins | Human with overweight subjects (39)-A randomized, double-blind, placebo-controlled clinical trial | 50 g/bw/p.o. | 60 days | Anti-diabetic and anti-obesity activity | [ |
| Navy bean | Total phenolics and anthocyanins | 3T3-L1 adipocytes | 50 g/bw/p.o. | 60 days | Anti-diabetic and anti-obesity activity | [ |
| Pinto bean | Delphinidin glucoside, petunidin glucoside, malvidin glucoside, anthocyanins, catechin, myricetin 3- | in vitro | 50 µL | 24 h | Anti-diabetic activity | [ |
| Kidney bean | Phenolic acids and bioactive peptide fractions | In vitro | <1, 1–3.5, 3.5–5, 5–10, and 10 kDa | 24 h | Anti-diabetic activity | [ |
| Black bean | Phenolic acids and bioactive peptide fractions | In vitro | 10.20 to 0.34 mg | 24 h | Anti-diabetic activity | [ |
| Black bean | Delphinidin-3- | Caco-2 cells | Anthocyanin solutions (1 mg/mL), purified anthocyanins | 24–36 h | Anti-diabetic activity | [ |
| Black bean | Total phenolic, tannins and anthocyanins | Human (56)-diabetic patients | 100 g of black bean | 3 months | Anti-diabetic activity | [ |
| Kidney bean | Total phenolic, tannins and anthocyanins | Wistar albino rats | 200 mg/kg bw | 30 days | Anti-diabetic activity | [ |
| Black bean | Total phenolic, tannins and anthocyanins | Wistar albino rats | 200 mg/kg bw | 45 days | Anti-diabetic activity | [ |
| Pinto bean | Total phenolics | Human (12)-randomized, double-blind, placebo-controlled study | 100 g/bw/p.o. | 3 h | Anti-diabetic activity | [ |
| Navy bean | Total phenolics | Human with diabetes (17)-randomized 4 × 4 crossover trial | 50 g/bw/p.o. | 24 h | Anti-diabetic activity | [ |
| Black bean | Total phenolics and anthocyanins | In vitro | 100 µg | 24 h | Anti-diabetic activity | [ |
| White kidney bean | Total phenolics | Wistar albino rats | 50 mg/kg bw/p.o. | 7 days | Anti-diabetic activity | [ |
| Black bean | Phenolic acids and bioactive peptide fractions | In vitro | 10.20–0.34 mg | 24 h | Anti-diabetic, and anti-hypertensive activities | [ |
| Zolfino landrace | Phenolic acids | in vitro | 700 µL | 24 h | Anti-diabetic, anti-oxidant and anti-inflammatory activities | [ |
| Kidney bean | Phenolic acids (chlorogenic acid, gallic acid, | Male Wistar rats | 0.4, 0.8 and 1.2 g/kg bw/p.o. for 6 weeks | 21 days | Anti-diabetic, hypolipidemic and cardioprotective activity | [ |
| Kidney bean | Lectins and polyphenol | 20–200 µg/mL | 24 h | Antifungal activity | [ | |
| Kidney bean | Total phenolics | Sprague-Dawley rats | 0, 7.5%, 15%, 30% or 60% | 7 days | Anti-hepatotoxic effect | [ |
| White and red bean | Ferulic, coumaric, Sinapic acid, Catechin, Malvidin 6- | Macrophages cell line RAW 264.7 | 20 µL | 36–48 h | Anti-inflammatory activity | [ |
| Navy and pinto bean | Phenolic acids and bioactive peptide fractions | RAW 264.7 macrophages | 1–3.5, 3.5–5, 5–10, and 10 kDa | 36–48 h | Anti-inflammatory activity | [ |
| Black, navy, kidney and pinto bean | (+)-catechin | 2.5, 5, 10, 12.5, 15 and 25 µg | 24 h | Anti-mutagenic activity | [ | |
| Black and kidney beans | Quercetin, kaempferol, | Sprague-Dawley rats and a diet-induced obesity model in C57Bl/6 mice | 7.5%, 15%, 30% or 60% | 7 days | Anti-obesity activity | [ |
| Black bean | Total phenolics | In vitro | 50–200 µL | 24 h | Anti-oxidant and anti-inflammatory activities | [ |
| Kidney bean | Flavonoids | HMEC-1 line | 0.7 mg | 36–48 h | Anti-oxidant and anti-inflammatory activities | [ |
| Black bean | Total phenolic, tannins and anthocyanins | Human (12)-randomized, controlled, crossover trial | 100 g of black bean meal and soup | 3 days | Anti-oxidant and anti-inflammatory activities | [ |
| Navy and black bean | Phenolic acids, flavonoids, and anthocyanins | C57BL/6 mice | 20% navy bean or black bean/p.o. | 2 weeks | Anti-oxidant and anti-inflammatory activities | [ |
| White and dark kidney beans | Phenolic acids, flavonoids, and anthocyanins | C57BL/6 mice | 20% navy bean or black bean/p.o. | 2 weeks | Anti-oxidant and anti-inflammatory activities | [ |
| Cranberry bean | Phenolic acids, flavonoids, and anthocyanins | C57BL/6 mice | 20% navy bean or black bean/p.o. | 2 weeks | Anti-oxidant and anti-inflammatory activities | [ |
| Navy and black beans | Phenolic acids, flavonoids, and anthocyanins | C57BL/6 mice | 20% navy bean or black bean/p.o. | 2 weeks | Anti-oxidant and anti-inflammatory activities | [ |
| Pinto, navy and black beans | (+)-catechin | 2.5, 5, 10, 12.5, 15 and 25 µg | 24 h | Anti-oxidant and anti-mutagenecity activities | [ | |
| Pinto, navy and black beans | Phenolic acids and Lectin-free fractions | Human erythrocytes and | 0.2 mg | 24 h | Anti-oxidant and anti-mutagenic effects | [ |
| Black and kidney beans | Catechin | In vitro | 50–100 µL | 24 h | Anti-oxidant and anti-mutagenic activities | [ |
| 12 varieties of non-pigmented bean, red bean, speckled bean, and dark bean | Gallic acid, chlorogenic acid, epicatechin, myricetin, formononetin, caffeic acid, and kaempferol | In vitro human epithelial colorectal adenocarcinoma (Caco-2) cells, breast cancer (MCF-7), and A549 NSCLC cell line | 15–300 µL | 36–48 h | Anti-oxidant and anti-proliferative Activities | [ |
| Black bean | Genistein, non-glycosylated flavonols | In vitro mammary gland, hepatic and colon cancer cell lines | 50–200 µL | 36–48 h | Anti-oxidant and anti-proliferative activities | [ |
| Black bean | Total phenolics | Wistar albino rats | 200 mg/kg bw/p.o. | 45 days- | Anti-oxidant anti-diabetic and anti-hyperlipidemic activities | [ |
| Dalia bean | Coumaric, salicylic, gallic, caffeic acids, epigallocatechin, rutin and quercetin, and flavonoids | In vitro | 100 µL | 24 h | Anti-oxidant activity | [ |
| Brazilian bean | Ferulic, sinapic, chlorogenic, and hydroxycinnamic acids | In vitro | 50 µL | 24 h | Anti-oxidant activity | [ |
| Pinto and black beans | Total phenolics, phenolic acids, isoflavones, and anthocyanins | In vitro | 50 µL | 24 h | Anti-oxidant activity | [ |
| Brazilian bean | Total phenolics, and phenolic acids | In vitro | 50–100 µL | 24 h | Anti-oxidant activity | [ |
| Black bean | Total phenolics | In vitro | 200 µL | 24 h | Anti-oxidant activity | [ |
| Yellow string bean | Total polyphenolics | In vitro | 10–100 µL | 24 h | Anti-oxidant activity | [ |
| Black bean | Total phenolics | Wistar albino rats | 200 mg/kg bw/p.o. | 45 days | Anti-oxidant activity | [ |
| Black bean | (+)-catechin, quercetin, vanillin and ellagic, caffeic, ferulic, gallic, chlorogenic, and sinapic acids | Human and in vitro | 1 g/p.o. | 36–48 h | Anti-oxidant activity and enhance gastrointestinal digestion and simulated colonic fermentation | [ |
| Dark bean | In vitro cell line cultures of Astrocytes (U-373), renal adenocarcinoma (TK-10), breast adenocarcinoma (MCF-7) and melanoma (UACC-62) | 700 µL | 36–48 h | Anti-oxidant, neuroprotective and anticancer activities | [ | |
| Kidney bean | Total phenolics | Female Sprague Dawley rats | 0, 7.5%, 15%, 30% or 60% | 46 days | Chemoprotective effect on breast cancer | [ |
| Black bean | Total phenolics | Female Sprague Dawley rats | 7.5%, 15%, 30% or 60% | 46 days | Chemoprotective effect on breast cancer | [ |
| Black, pinto and kidney beans | Tannins | Male Sprague–Dawley rats | 7.5%, 15%, 30% or 60% | 46 days | Chemoprotective effect on breast cancer | [ |
| Black bean | Tannins | Male Sprague–Dawley rats | 2.5 g/kg bw/p.o. | 9 weeks | Chemoprotective effect on colon cancer | [ |
| Black and navy beans | Tannins | Male Sprague–Dawley rats | 2.5 g/kg bw/p.o. | 9 weeks | Chemoprotective effect on colon cancer | [ |
| Black beans | Tannins | Male Sprague–Dawley rats | 2.5 g/kg bw/p.o. | 9 weeks | Chemoprotective effect on colon cancer | [ |
| Kidney bean | Tannins | Human HT-29 cell lines | 100 µL | 48 h | Chemoprotective effect on colon cancer | [ |
| Kidney bean | Tannins | Sprague–Dawley rats and | 2.5 g/kg bw/p.o. | 9 weeks | Chemoprotective effect on colon cancer | [ |
| Black bean | (+)-catechin | Human HT-29 cell lines | 20 mg | 48 h | Chemoprotective effect on colon cancer | [ |
| Black bean | Flavonoids | In vitro | 5 mg | 24 h | Cholesterol-lowering effects | [ |
| Black bean | Orientin, isoorientin, rutin myricetin-3- | Male Wistar rats | 2% bean seed coat extract/p.o. | 7 days | Hypoglycemic and hypolipidemic effects | [ |
| Black bean | Total phenolics | Wistar albino rats | 200 mg/kg bw/p.o. | 45 days | Hypoglycemic and hypolipidemic effects | [ |
| Black bean | Flavonoids | Male Wistar rats | 200, 400 mg/kg bw | 7 days | Hypoglycemic effect | [ |
| Navy and pinto beans | Flavonoids | Male Wistar rats | 50, 200, 500 mg/kg bw | 15 days | Hypoglycemic effect and anti-obesity effect | [ |
| Kidney bean | Flavonoids | Male Wistar rats | 50, 200, 500 mg/kg bw | 21 days | Hypoglycemic effect and anti-obesity effect | [ |
| Black bean | Flavonoids | Obese Zucker fa/fa rats | 50 and 500 mg/kg bw | 3–7 days, | Hypoglycemic effect and anti-obesity effect | [ |
| Black bean | Catechin | Male Wistar rats | 50 mg/kg bw | 21 days | Hypoglycemic effect and anti-obesity effect | [ |
| Black bean | Flavonoids | CD1 mice | 200, 400 mg/kg bw | 45 days | Hypoglycemic effect and anti-obesity effect | [ |
| Black bean | Total phenolic, tannins and anthocyanins | CD1 mice | 200, 400 mg/kg bw | 21 days | Hypoglycemic effect and anti-obesity effect | [ |
| Black bean | Quercetin 3- | Rat hepatocytes and C57BL/6 mice | 25 mg | 48 h | Hypolipidemic activity | [ |
Expansion: b.w- body weight; w/w- weight/weight; p.o.- per oral.